American Association For Cancer Research Announces New Editor-in-Chief Of Cancer Research
Main Category: Cancer / OncologyArticle Date: 07 May 2009 - 4:00 PDT
| Patient / Public: | ![]() |
4 (1 votes) |
| Healthcare Prof: | ![]() |
4.5 (2 votes) |
The American Association for Cancer Research is pleased to announce that George Prendergast, Ph.D., has been appointed editor-in-chief of Cancer Research, the oldest journal of the American Association for Cancer Research.
Prendergast, president and CEO of Lankenau Institute for Medical Research in Wynnewood, Pa., will assume the post on January 1, 2010, and serve for five years.
"My goal is to make Cancer Research the top journal for those scientists who are interested in the management and eradication of cancer," said Prendergast. "There are other journals that present different perspectives on the problem of cancer, but Cancer Research will be the 'go to' source for laboratory and translational scientists who are interested in real improvements rather than just interesting concepts."
Cancer Research is published twice a month, and will celebrate its 70th year of publication in 2011.
"The American Association for Cancer Research is proud to have a prominent scientist like Dr. Prendergast take lead of our premier journal," said Margaret Foti, Ph.D., M.D. (h.c.), CEO of the American Association for Cancer Research. "His in-depth knowledge of the biological basis for drug development and molecular underpinnings of cancer will help drive the field forward."
Prendergast had previously served as a senior editor and deputy editor for Cancer Research. He has been honored with numerous accolades from the Pew Foundation, the National Institutes of Health and the American Cancer Society. His primary research interests include the molecular and cellular biology of cancer, cancer immunology, preclinical models of cancer progression and therapy and drug discovery and mechanisms. He is an author on several early scientific papers on the mechanisms of action for drugs that are now in clinical development.
Prendergast received his doctorate in molecular biology from Princeton University in 1989, a Master of Science in molecular biophysics and biochemistry from Yale University in 1984 and a Bachelor of Arts in biochemistry from the University of Pennsylvania in 1983.
Source
American Association for Cancer Research
Visit our cancer / oncology section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/149201.php>
APA
http://www.medicalnewstoday.com/releases/149201.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





